Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo-Reference-Cited by-同舟云学术

Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

Published:2011-05-30 Issue:3 Volume:47 Page:342-351
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Olivieri A, ,Marchetti M,Lemoli R,Tarella C,Iacone A,Lanza F,Rambaldi A,Bosi A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201182.pdf

Reference121 articles.

1. Dreyling M, Hiddemann W . Current treatment standards and emerging strategies in mantle cell lymphoma. Hematol Am Soc Hematol Educ Program 2009, 542–551.

2. Foster M, Gabriel DA, Shea T . Role of hematopoietic stem cell transplant in the management of follicular lymphoma. Oncologist 2009; 14: 726–738.

3. Harousseau J, Attal M . The role of autologous hematopoietic stem cell transplantation in multiple myeloma. Semin Hematol 1997; 34 (Suppl 1): 61–66.

4. Hernandez-Ilizaliturri FJ, Czuczman MS . Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma. Part 2. Novel therapeutic strategies. Oncology (Williston Park) 2009; 23: 610–615.

5. Moskowitz AJ, Moskowitz CH . Controversies in the treatment of lymphoma with autologous transplantation. Oncologist 2009; 14: 921–929.

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy;Annals of Hematology;2024-08-22

2. Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group;Cancers;2024-07-19

3. Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma;Frontiers in Immunology;2024-07-18

4. Focus on: Prognostic scores to predict stem cell mobilization;Transfusion and Apheresis Science;2024-06

5. How to manage poor mobilisers;Transfusion and Apheresis Science;2024-06